- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-05-0002090

Ybrex Pharmaceuticals Private Limited
About Ybrex Pharmaceuticals Private Limited
Data last updated:
Ybrex Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 28 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2017PTC068837. Its GSTIN is 09AAACY8888K1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sandeep Kumar and Vibha Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gurgaon, Haryana.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.35 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹85,009 (net margin 5.5%) and EBITDA of ₹87,848 (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years and 14% over five years.
Ybrex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0002090). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Ybrex Pharmaceuticals
Contact details
Ybrex Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address559 1/23 2nd Floor Laxmi Garden, Gururgram, Gurgaon, Haryana, India – 122001
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Ybrex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ybrex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ybrex Pharmaceuticals Private Limited, buy the company report.
Financials of Ybrex Pharmaceuticals Private Limited
FY 2025 filings availableYbrex Pharmaceuticals Private Limited reported revenue of ₹15.35 Lakh (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,848 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹85,009 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ybrex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ybrex Pharmaceuticals Private Limited
Ybrex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar | Director | 28 Apr 2017 | 9 Years 6 Months | Current |
| Vibha Arora | Director | 28 Apr 2017 | 9 Years 6 Months | Current |
Peer comparison
Ybrex Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Diar Pharmaceuticals Private Limited | ₹15.46 Lakh (FY 2022) | -19.0% | New Delhi, Delhi, India | |||
| Magadh Pharmaceuticals Private Limited | ₹15.44 Lakh (FY 2024) | -6.0% | Patna, Bihar, India | |||
| Ybrex Pharmaceuticals Private Limitedthis company | ₹15.35 Lakh (FY 2024) | ₹85,009 | 5.5% | -1.0% | Gurgaon, Haryana, India | |
| Mehnoor Pharmaceuticals Private Limited | ₹15.29 Lakh (FY 2018) | Bahraich, Uttar Pradesh, India | ||||
| Cato Pharmaceuticals Private Limited | ₹15.29 Lakh (FY 2018) | Kakinada, Andhra Pradesh, India |
To see the full peer comparison of Ybrex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ybrex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ybrex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ybrex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACY8888K1ZB | Uttar Pradesh | Active | 27 Jul 2017 |
To see the full GST registrations and return filing status of Ybrex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ybrex Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Sandeep Kumar was appointed as Director on 28 Apr 2017.
Frequently asked questions
Ybrex Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 28 April 2017 (9+ years old) and is registered under CIN U24304HR2017PTC068837.
Ybrex Pharmaceuticals has 2 current directors:
- Sandeep Kumar - Director
- Vibha Arora - Director
The latest financial statements of Ybrex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ybrex Pharmaceuticals is 09AAACY8888K1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ybrex Pharmaceuticals is U24304HR2017PTC068837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ybrex Pharmaceuticals was incorporated on 28 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Ybrex Pharmaceuticals by revenue are Diar Pharmaceuticals Private Limited, Magadh Pharmaceuticals Private Limited, Mehnoor Pharmaceuticals Private Limited, Cato Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sandeep Kumar was appointed as Director on 28 Apr 2017. Vibha Arora was appointed as Director on 28 Apr 2017.
Yes, Ybrex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0002090).
The registered office of Ybrex Pharmaceuticals is at 559 123 2nd Floor Laxmi Garden, Gururgram, Gurgaon, Haryana, India – 122001.
Ybrex Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.

